Evidence map›Paper›PMID 23566117›Full record

ArticleThe journal of sexual medicine2013

Activated Rho kinase mediates diabetes-induced elevation of vascular arginase activation and contributes to impaired corpora cavernosa relaxation: possible involvement of p38 MAPK activation.

Haroldo A Toque, Kenia P Nunes, Lin Yao, James K Liao, R Clinton Webb, Ruth B Caldwell, R William Caldwell

Abstract read
In one paragraph

Article in The journal of sexual medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Supplementation withMarine drugs · 2022
    Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Liraglutide Ameliorates Erectile DysfunctionFrontiers in pharmacology · 2020
    Article
  13. Potential Therapeutic Role of Dietary Supplementation withOxidative medicine and cellular longevity · 2020
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Haroldo A ToqueDepartment of Pharmacology & Toxicology, Georgia Health Sciences University, Augusta, GA 30912-2300, USA. hflorestoque@georgiahealth.edu
Kenia P Nunes
Lin Yao
James K Liao
R Clinton Webb
Ruth B Caldwell
R William Caldwell
Augusta University Health · USAugusta University · USCenter for Vascular Biology Research · USUniversity of Chicago · US

Funding

Cellular Mechanisms of Retinopathy: Role of ArginaseR01EY011766 · NEI · MEDICAL COLLEGE OF GEORGIA (MCG) · PI CALDWELL, ROBERT WILLIAM, CALDWELL, RUTH B · 1998 to 2021
$6.7M
LIPOPROTEINS EFFECTS ON G PROTEIN FUNCTIONR01HL052233 · NHLBI · UNIVERSITY OF CHICAGO · PI LIAO, JAMES KUANG-JAN · 1995 to 2016
$5.3M
L-arginine metabolism in diabetes-induced coronary dysfunctionR01HL070215 · NHLBI · MEDICAL COLLEGE OF GEORGIA (MCG) · PI CALDWELL, ROBERT WILLIAM · 2002 to 2011
$2.3M
Novel Signaling Pathways in Ischemic StrokeR01NS070001 · NINDS · UNIVERSITY OF CHICAGO · PI LIAO, JAMES KUANG-JAN · 2010 to 2014
$1.8M
ROCK and ObesityR01DK085006 · NIDDK · UNIVERSITY OF CHICAGO · PI LIAO, JAMES KUANG-JAN · 2010 to 2014
$1.7M
NEI NIH HHS EY-11766NEI NIH HHS R01 EY011766NHLBI NIH HHS HL052233NHLBI NIH HHS HL-70215NHLBI NIH HHS R01 HL052233NHLBI NIH HHS R01 HL070215NIDDK NIH HHS DK085006NIDDK NIH HHS R01 DK085006NINDS NIH HHS R01 NS070001
6 · The paper itself

Abstract

introductionActivated RhoA/Rho kinase (ROCK) has been implicated in diabetes-induced erectile dysfunction. Earlier studies have demonstrated involvement of ROCK pathway in the activation of arginase in endothelial cells. However, signaling pathways activated by ROCK in the penis remain unclear.

aimWe tested whether ROCK and p38 MAPK are involved in the elevation of arginase activity and subsequent impairment of corpora cavernosal (CC) relaxation in diabetes.

methodsEight weeks after streptozotocin-induced diabetes, vascular functional studies, arginase activity assay, and protein expression of RhoA, ROCK, phospho-p38 MAPK, p38 MAPK, phospho-MYPT-1(Thr850), MYPT-1 and arginase levels were assessed in CC tissues from nondiabetic wild type (WT), diabetic (D) WT (WT + D), partial ROCK 2(+/-) knockout (KO), and ROCK 2(+/-) KO + D mice.

main outcome measuresThe expression of RhoA, ROCK 1 and 2, phosphorylation of MYPT-1(Thr850) and p38 MAPK, arginase activity/expression, endothelial- and nitrergic-dependent relaxation of CC was assayed.

resultsDiabetes significantly reduced maximum relaxation (Emax ) to both endothelium-dependent acetylcholine (WT + D: Emax; 61 ± 4% vs. WT: Emax; 75 ± 2%) and nitrergic nerve stimulation. These effects were associated with increased expression of active RhoA, ROCK 2, phospho-MYPT-1(Thr850), phospho-p38 MAPK, arginase II, and activity of corporal arginase (1.6-fold) in WT diabetic CC. However, this impairment in CC of WT + D mice was absent in heterozygous ROCK 2(+/-) KO + D mice for acetylcholine (Emax : 80 ± 5%) and attenuated for nitrergic nerve-induced relaxation. CC of ROCK 2(+/-) KO + D mice showed much less ROCK activity, did not exhibit p38 MAPK activation, and had reduced arginase activity and arginase II expression. These findings indicate that ROCK 2 mediates diabetes-induced elevation of arginase activity. Additionally, pretreatment of WT diabetic CC with inhibitors of arginase (ABH) or p38 MAPK (SB203580) partially prevented impairment of ACh- and nitrergic nerve-induced relaxation and elevation of arginase activity.

conclusionROCK 2, p38 MAPK and arginase play key roles in diabetes-induced impairment of CC relaxation.

Indexed as

AnimalsArginaseDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 1Diabetic AngiopathiesDose-Response Relationship, DrugElectric StimulationEndothelium, VascularEnzyme ActivationHaploinsufficiencyMaleMiceMice, Inbred C57BLMice, KnockoutMyosin-Light-Chain KinaseMyosin-Light-Chain PhosphataseArg1 protein, mouseArg2 protein, mouseArginaseMyosin-Light-Chain KinaseMyosin-Light-Chain Phosphatasep38 Mitogen-Activated Protein KinasesPpp1r12a protein, mouseProtein Kinase InhibitorsrhoA GTP-Binding ProteinRhoA protein, mouserho-Associated Kinasesrho GTP-Binding ProteinsRock1 protein, mouseRock2 protein, mouseVasodilator Agents

Identifiers

PMID23566117
PMCPMC3807104
OpenAlexW1481109427

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.